For health care professionals only

The information contained on this website is intended for use only by health care professionals in the United States. Countries outside of the United States may have different regulatory requirements or medical practices than the United States. Therefore, this information may not be appropriate for use outside of the United States.

Are you a health care professional in the United States?

You will now be leaving the NovoSeven® RT website.

Stopping bleeds Bleed
In hemophilia, a collection of blood in an area, such as a muscle or joint. quickly is important. The faster you treat a bleed, the sooner you can start to recover.

NovoSeven® RT provides rapid initiation and administration to treat bleeds fast*

  • 94% less infusion Infusion
    The injection of medicine directly into a vein using a needle and syringe.     volume than plasma Plasma
    The fluid part of the blood that contains clotting factors and other proteins.     -derived bypassing agents Bypassing agent
    A product that treats a bleed without the need for Factor VIII (8) or Factor IX (9).     (FEIBA®)†
  • Takes 2 to 5 minutes to administer Administer
    In hemophilia, to apply to the body through infusion.
  • Can be stored at room temperature (up to 77°F)
  • Comes in 4 vial sizes: 1 mg, 2 mg, 5 mg, and 8 mg

*In patients with hemophilia A or B with inhibitors.
†Individual doses compared.

Rapid reconstitution with NovoSeven® RT just got faster‡

vials

‡Based on previous NovoSeven® RT reconstitution
regimen for appropriate patient types.